Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 5:59 pm Sale | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Venrock Healthcare Capital Partners III, L.P. | 639,088 3.200% | -459,908 (-41.85%) | Filing History |
| 2025-08-14 5:28 pm Purchase | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 1,527,930 7.600% | 528,516 (+52.88%) | Filing History |
| 2025-08-14 4:30 pm Sale | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Canaan XII L.P. | 0 0.000% | -1,400,000 (Position Closed) | Filing History |
| 2025-08-14 4:00 pm Purchase | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | BCLS Fund III Investments, LP | 2,500,680 9.990% | 1,797,600 (+255.68%) | Filing History |
| 2025-08-12 8:50 pm Purchase | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Vivo Opportunity Fund Holdings, L.P. | 1,175,796 4.600% | 563,520 (+92.04%) | Filing History |
| 2025-08-12 09:02 am Purchase | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Adage Capital Management L.P. | 1,100,000 4.970% | 110,000 (+11.11%) | Filing History |
| 2025-08-11 4:43 pm Unchanged | 2025-08-07 | 13D | Cidara Therapeutics, Inc. CDTX | RA Capital Management, L.P. | 3,365,523 13.300% | 0 (Unchanged) | Filing History |
| 2025-07-30 4:14 pm Purchase | 2025-07-23 | 13G | Cidara Therapeutics, Inc. CDTX | Paradigm Biocapital Advisors LP | 1,128,613 5.600% | 1,128,613 (New Position) | Filing History |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | BlackRock Inc. BLK | 1,107,668 5.500% | 1,107,668 (New Position) | Filing History |
| 2025-07-02 4:32 pm Purchase | 2025-06-25 | 13G | Cidara Therapeutics, Inc. CDTX | Commodore Capital LP | 1,175,000 5.500% | 1,175,000 (New Position) | Filing History |
| 2025-06-30 5:05 pm Purchase | 2025-06-26 | 13D | Cidara Therapeutics, Inc. CDTX | RA Capital Management, L.P. | 3,365,523 15.800% | 2,272,727 (+207.97%) | Filing History |
| 2025-05-15 5:47 pm Sale | 2025-03-31 | 13G | Cidara Therapeutics, Inc. CDTX | Venrock Healthcare Capital Partners III, L.P. | 1,098,996 9.900% | -30,101 (-2.67%) | Filing History |
| 2025-05-15 4:25 pm Purchase | 2025-03-31 | 13G | Cidara Therapeutics, Inc. CDTX | BIOTECHNOLOGY VALUE FUND L P | 1,252,441 9.990% | 158,942 (+14.54%) | Filing History |
| 2025-05-15 08:31 am Purchase | 2025-03-31 | 13G | Cidara Therapeutics, Inc. CDTX | Vivo Opportunity Fund Holdings, L.P. | 612,276 4.700% | 12,119 (+2.02%) | Filing History |
| 2025-05-12 09:04 am Purchase | 2025-03-31 | 13G | Cidara Therapeutics, Inc. CDTX | Adage Capital Management L.P. | 990,000 9.040% | 990,000 (New Position) | Filing History |
| 2025-04-16 4:56 pm Purchase | 2025-04-09 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 999,414 9.100% | 999,414 (New Position) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | BIOTECHNOLOGY VALUE FUND L P | 1,093,499 9.990% | 390,373 (+55.52%) | Filing History |
| 2024-12-09 5:37 pm Purchase | 2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX | Vivo Opportunity Fund Holdings, L.P. | 600,157 5.500% | 600,157 (New Position) | Filing History |
| 2024-12-04 4:15 pm Purchase | 2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX | Venrock Healthcare Capital Partners III, L.P. | 1,129,097 9.990% | 1,129,097 (New Position) | Filing History |
| 2024-12-03 4:34 pm Purchase | 2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX | TCG Crossover GP II, LLC | 1,005,901 9.200% | 1,005,901 (New Position) | Filing History |